Glycoprotein B (EBV)

Glycoprotein B (EBV)

Glycoprotein B (EBV) Informations sur la molécule

Molecule Name
Envelope glycoprotein B, gB
Alias de la molécule
gB
Drug Development Progress
Nombre de médicaments cliniques2
Nombre de médicaments commercialisés0
Phase de R&D la plus avancéePhase 2 Clinical
Alias de la cible
UL55
Contexte de la molécule
Epstein-Bar Virus (EBV), also known as human herpesvirus 4, belongs to gamma herpes virus family and is a very common human virus worldwide. EBV causes infectious mononucleosis (IM) and also associates to some specific types of cancers such as Burkitt’s lymphoma (BL) and gastric carcinoma (GC). Glycoprotein B (gB) plays an important role in viral entry by binding with αvβ6/αvβ8 integrins to trigger the membrane fusion and entry process of epithelial cells, which makes it become an great target for EBV research.

Demande de produit

Asset Licensing Opportunity
Resources

Informations sur les médicaments cliniques

Nom anglaisCode de recherchePhase de R&DEntrepriseIndicationEssai clinique
FiztasovimabNPC-21Phase 2 ClinicalNobelpharma Co Ltd
Cytomegalovirus Infections
Details
TRL-345CMV-345; TRL-345Phase 1 ClinicalTrellis Bioscience LLC
Cytomegalovirus Infections
Details
Customer Reviews